KURTIS KRUEGER (CARDIOVASCULAR DISEASE (CARDIOLOGY)) Reviews and Ratings

About KURTIS KRUEGER

KURTIS KRUEGER: Education and Training:

Mr. KURTIS KRUEGER attended OTHER, graduating in 1981.

Specialties and Sub-Specialties:

KURTIS KRUEGER is a specialist in CARDIOVASCULAR DISEASE (CARDIOLOGY). No other specialties were noted.

CARDIOVASCULAR DISEASE (CARDIOLOGY): These surgeons operate on the blood vessels throughout the body. They often operate on the aorta (the main artery in the body), carotid arteries (blood vessels to the brain) and they treat varicose veins in the legs. (more information)

National Provider Number (NPI):

1366465858

KURTIS KRUEGER Reviews and Ratings

MIPS Scores for KURTIS KRUEGER

MIPS is an acronym for Merit-Based Incentive Payment System. Authorized by the Medicare Access and CHIP Reaouthorization Act of 2015, the Centers for Medicare & Medicaid Services ("CMS") developed MIPS to reward clinicians for the value of care they provide rather than the volume of care, quality over quantity. The MIPS final score determines a provider's Medicare Part B payment adjustments. MIPS also created a means for consumers to rank providers.

MIPS scores are calculated using four performance categories, quality, cost, improvement activities, and promotion of interoperability. Higher scores are better. The highest final MIPS score is 100.

Final MIPS Score	89.3
Final MIPS Score without CPB	84.1
PI Category Score	60.1
IA Category Score	40
Quality Category Score	92

Measures and Activities

These are important measures that CMS tracks for each doctor. Not all doctors or medical professionals have data.

Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
Diabetes: Medical Attention for Nephropathy
Advance Care Plan
Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy
Coronary Artery Disease (CAD): Antiplatelet Therapy
Provide Patients Electronic Access to Their Health Information
e-Prescribing
Clinical Data Registry Reporting	Yes
Clinical Data Registry Reporting for Multiple Registry Engagement	Yes
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)	74%
Coronary Artery Disease (CAD): Beta-Blocker Therapy - Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%)	82%
Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)	91%
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)	95%
Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)	68%
Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control)	73%
ONC Direct Review Attestation	Yes
ONC-ACB Surveillance Attestation	Yes
Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record	Yes
Regularly assess the patient experience of care through surveys, advisory councils and/or other mechanisms.	Yes
Security Risk Analysis	Yes
Support Electronic Referral Loops By Receiving and Incorporating Health Information Exclusion	Yes
Support Electronic Referral Loops By Sending Health Information Exclusion	Yes